We are an international
independent scientific network

devoted to advancing research on optimising the prevention,
diagnosis and treatment of infectious diseases in children globally

Linking experts from
around the world

in an independent global collaboration that seeks to standardize
best practices across disease areas and populations

Sharing values and goals

such as flexibility, commitment and transparency

Researching the right drug
and the right dose

to generate the scientific data necessary to market drugs
at doses that are safe and effective for children

Understanding the
immune response

so as to harness the body's response
to HIV and antiretrovirals

Fighting
antimicrobial resistance

to ensure effective treatments are available
for common infections for generations to come

Paving the way for women,
children and their families

to make powerful informed decisions about their health
and healthcare and improve the quality of their lives

Get to know us

Penta is an international independent scientific network dedicated to child health. Our work is the result of a passionate collaboration between healthcare professionals and researchers in more than 110 centres across 31 countries around the world.

Through our studies and partnerships, we develop and deliver world-class research and training in paediatric infectious diseases to improve the lives of women and children, wherever they live.

Are you interested joining the Penta ID Network? Complete this form to apply.

Current Penta studies around the World

Always expanding

Penta continues to grow, bringing together healthcare professionals, researchers and scientists worldwide to address a wide range of healthcare issues.
0

Members

0

Countries

0

Years of activity

0

Ongoing studies and projects

Latest News

VERDI poster wins “Best Poster” Award at ESPID 2024!

12 Jun, 2024

We are pleased to announce that the poster “SARS-CoV-2 Infection Incidence and Severity in Immunocompromised Children: A Population-Based Study in Italy and Norway” has received the Best Poster Award from the ESPID Committee for…
Read More

A Europe-wide push to improve care for premature babies: New study explores benefits of kangaroo care on reducing infections in NICUs

04 Jun, 2024

Padova, 3 June 2024 – A new European multicenter study, named NeoDeco, will investigate whether optimised kangaroo care can reduce infection rates in preterm babies in neonatal intensive care units…
Read More

HVRRICANE study makes significant progress in paediatric HIV research

27 May, 2024

We are pleased to announce the successful completion of recruitment for the HVRRICANE study. The study, a collaboration between Penta, Bambino Gesù Paediatric Hospital in Rome (OPBG), the Henry M.…
Read More

EARTH study reveals high mortality rates among infants with HIV despite early treatment 

24 May, 2024

EPIICAL’s EARTH Study reveals challenges persist for infants in Africa with HIV despite early treatment The EARTH study findings published in eClinical Medicine shed light on the ongoing struggle for…
Read More

Four-day antibiotic treatment shows promise for childhood pneumonia in Africa

17 May, 2024

The PediCAP consortium, a global partnership of 14 institutions, presented promising results from its main trial, PediCAP-A, at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) conference…
Read More

Keep up to date with the latest Penta news

Sign up to receive our monthly Penta Newsletter filled with the latest news on our studies, projects and people